The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Backenroth Samuel since 2015.
This trader's CIK number is 1579887.
At the time of last reporting, Backenroth Samuel was the Chief Financial Officer of Vascular Biogenics Ltd.. (stock ticker symbol VBLT).
Also see all insider trading activities at Vascular Biogenics Ltd..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | VBLT | 0 | $0 | 0 | $0 | 525,000 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | NBSE | 1,000 | $6,000 | 0 | $0 | 0 | $0 |
| 2017 | NBSE | 71,429 | $50,000 | 0 | $0 | 0 | $0 |
| 2016 | NBSE | 9,904 | $28,929 | 0 | $0 | 0 | $0 |
| 2015 | NBSE | 1,500 | $10,125 | 0 | $0 | 0 | $0 |
1. Vascular Biogenics Ltd. (VBLT)
2. Neubase Therapeutics, Inc. (NBSE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-31 | VBLT | Option Ex | 525,000 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-04-30 | NBSE | Buy | 1,000 | 6.00 | 6,000 |
| 2017-04-10 | OHRP | Buy | 71,429 | .70 | 50,000 |
| 2016-06-20 | OHRP | Buy | 2,468 | 2.84 | 7,004 |
| 2016-06-20 | OHRP | Buy | 2,468 | 2.84 | 7,004 |
| 2016-06-20 | OHRP | Buy | 2,468 | 2.84 | 7,004 |
| 2016-05-23 | OHRP | Buy | 2,500 | 3.17 | 7,917 |
| 2015-02-06 | OHRP | Buy | 1,500 | 6.75 | 10,125 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Backenroth Samuel (Chief Financial Officer of Vascular Biogenics Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.